241
Participants
Start Date
May 5, 2003
Primary Completion Date
January 29, 2004
Study Completion Date
January 29, 2004
insulin aspart
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Nyíregyháza
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Chiavari
Novo Nordisk Investigational Site, Parma
Novo Nordisk Investigational Site, Marl
Novo Nordisk Investigational Site, Rimini
Novo Nordisk Investigational Site, Bad Neuenahr-Ahrweiler
Novo Nordisk Investigational Site, Lucca
Novo Nordisk Investigational Site, Simmern
Novo Nordisk Investigational Site, Bad Kreuznach
Novo Nordisk Investigational Site, Frankfurt
Novo Nordisk Investigational Site, Oberursel
Novo Nordisk Investigational Site, Diez
Novo Nordisk Investigational Site, Saarbrücken
Novo Nordisk Investigational Site, Friedrichsthal
Novo Nordisk Investigational Site, Saint Ingbert
Novo Nordisk Investigational Site, Rehlingen-Siersburg
Novo Nordisk Investigational Site, Speyer
Novo Nordisk Investigational Site, Karlsruhe
Novo Nordisk Investigational Site, Würzburg
Novo Nordisk Investigational Site, Marktheidenfeld
Novo Nordisk Investigational Site, Hradec Králové
Novo Nordisk Investigational Site, Cagliari
Novo Nordisk Investigational Site, Città di Castello
Novo Nordisk Investigational Site, Orvieto
Novo Nordisk Investigational Site, Perugia
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Bytom
Novo Nordisk Investigational Site, Mazowieckie
Novo Nordisk Investigational Site, Radom
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Wroclaw
Lead Sponsor
Novo Nordisk A/S
INDUSTRY